AHS to Launch $750 Million Casa AHS on Dubai Water Canal
With a robust pipeline, AHS Properties aims to reach a GDV of $5 billion
AHS Properties, the UAE’s leading ultra-luxury real estate developer, has announced the launch of Casa AHS, a landmark waterfront development valued at $750 million (AED 2.75 billion). Set along the prestigious Dubai Water Canal, the project redefines elite urban living with a curated collection of exceptional residences.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520255397/en/
AHS to Launch $750 Million Casa AHS on Dubai Water Canal (photo: AETOSWire)
Casa AHS is designed as a rare blend of architectural brilliance and branded elegance. The development is crafted by acclaimed architect Shaun Killa, with interiors by the renowned HBA Residential—redefining grandeur with expansive layouts, double-height ceilings (up to 12 meters), and awe-inspiring views of the Dubai Water Canal and Safa Park.
Commenting on the launch, Abbas Sajwani, Founder and CEO of AHS Properties, said: “With Casa AHS, we are creating more than just homes, we are curating a lifestyle that is deeply refined, emotionally resonant, and globally admired. This launch is a continuation of our mission to elevate luxury living in Dubai and offer our clients rare, statement-making properties in prime waterfront locations.”
The development will offer 32 ultra-luxury residences, including Sky Villas, Sky Mansions, and Sky Palaces, with sizes ranging from 5,088 to 29,700 sq. ft. Each residence features private elevators opening directly into lavish living rooms, private infinity-edge pools that seamlessly blend with the canal’s serene waters, jacuzzis, and expansive terraces for both tranquil relaxation and sophisticated entertaining.
Residents will enjoy a host of five-star amenities, including a private lounge and resident workspace, a tranquil spa and wellness oasis, and 24/7 concierge services accessible via a resident-only app. Additional offerings include exclusive access to a curated ultra-high-net-worth (UHNW) network, chauffeured limousine services and round-the-clock housekeeping. Each residence also comes with fully enclosed private garages, electric vehicle charging stations, dedicated bicycle storage, and secured private storage rooms.
About AHS Properties:
Founded in 2017 by Abbas Sajwani, AHS Group today boasts an impressive asset value of $2.7 billion and employs over 3,000 individuals, with ambitious plans to become one of the most vibrant business groups in the region. With a robust pipeline, AHS Properties targets $5 billion in GDV by the end of this year, continuing to set benchmarks in the luxury real estate market.
The company has achieved remarkable milestones, including the sale of high-value properties and the introduction of Casa Canal with Fendi Casa interiors.
In 2020, AHS Investments was launched, building a $150 million diversified portfolio across private and public equity. In 2021, Abbas launched AHS Properties, entering the luxury real estate market with projects in Palm Jumeirah and Emirates Hills, quickly earning recognition for innovation and quality.
New projects are on the horizon, promising to elevate luxury living. Each development is thoughtfully curated to offer unique experiences and expand the AHS portfolio, continuing our journey to set new benchmarks in the real estate landscape.
Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20250520255397/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release
Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release
IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release
Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom